-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Acumen Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2024.
- Acumen Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$32.3M, a 101% decline year-over-year.
- Acumen Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$92.9M, a 63.3% decline year-over-year.
- Acumen Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$61.1M, a 35.2% decline from 2022.
- Acumen Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$45.2M, a 131% decline from 2021.
- Acumen Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$19.6M, a 148% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)